Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine

How can we make the results of trials and their meta-analyses using continuous outcomes clinically interpretable?

(2014) T. A. Furukawa   ACTA PSYCHIATRICA SCANDINAVICA

Pharmacological management of unipolar depression

(2013) G. S. Malhi et al.   ACTA PSYCHIATRICA SCANDINAVICA

Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians

(2013) Gerald Gartlehner et al.   ANNALS OF INTERNAL MEDICINE

Sponsorship, Antidepressant Dose, and Outcome in Major Depressive Disorder

(2012) Mark Sinyor et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies

(2011) Florian Naudet et al.   PLoS One

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE